| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 176182-04-0 | Polygalasaponin XXXII | C79H118O38 |
| 176182-06-2 | (2S,3R,4S)-3-Ethenyl-2-(beta-D-glucopyranosyloxy)-4-[2-[[3-(beta-D-glucopyranosyloxy)-2-hydroxybenzoyl]oxy]ethyl]-3,4-dihydro-2H-pyran-5-carboxylic acid methyl ester | C30H40O18 |
| 176199-35-2 | Boc-D-4-iodophenylalanine | C14H18INO4 |
| 176199-48-7 | Eglumegad | C8H11NO4 |
| 176219-04-8 | Omeprazole N-oxide | C17H19N3O4S |
| 176220-38-5 | 4,4'-Bis(diethylmethylphosphonate)-2,2'-bipyridine | C20H30N2O6P2 |
| 176225-08-4 | 2-Bromo-5-(trifluoromethyl)benzenesulfonyl chloride | C7H3BrClF3O2S |
| 176225-09-5 | 4-Fluoro-2-(trifluoromethyl)benzenesulfonyl chloride | C7H3ClF4O2S |
| 176225-10-8 | 4-Bromo-2-(trifluoromethyl)benzenesulfonyl chloride | C7H3BrClF3O2S |
| 176237-44-8 | 5-Hydroxy-N-[(phenylmethoxy)carbonyl]-L-norvaline isopropyl ester | C16H23NO5 |
| 176237-45-9 | 5-[(Methylsulfonyl)oxy]-N-[(phenylmethoxy)carbonyl]-L-norvaline isopropyl ester | C17H25NO7S |
| 176252-20-3 | Plerixafor Impurity I | C18H32N4O |
| 176254-10-7 | (17alpha)-13-Ethyl-3-methoxy-18,19-dinorpregna-3,5-dien-20-yn-17-ol | C22H30O2 |
| 176258-88-1 | 4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzeneacetamide | C14H9I4NO3 |
| 176298-44-5 | 1,4-Bis(dihydroquinidine)anthraquinone | C54H56N4O6 |
| 176300-66-6 | D-Selenocysteine | C3H7NO2Se |
| 176317-02-5 | 2,3,4-Trifluorobromobenzene | C6H2BrF3 |
| 176324-61-1 / 132910-76-0 | 2-Ethenyl-1-piperidinecarboxylic acid 1,1-dimethylethyl ester | C12H21NO2 |
| 176325-83-0 | (Trimethylphosphoranylidene)acetonitrile | C5H10NP |
| 176374-86-0 | 4-(Trifluoromethyl)-2-(2,2,2-trifluoroethoxy)-3-(heptafluoroisopropyl)-1,1,1,4,5,5,5-heptafluoro-2-pentene | C11H2F20O |
| 176375-41-0 | Methyl 4-(4-formyl-2-methoxyphenoxy)butyrate | C13H16O5 |
| 176375-43-2 | Methyl 4-(4-hydroxymethyl-2-methoxy-5-nitrophenoxy)butyrate | C13H17NO7 |
| 176380-53-3 | N-Fmoc-L-threonol | C19H21NO4 |
| 176390-66-2 | 3beta,16alpha-Dihydroxylanosta-7,9(11),24-trien-21-oic acid | C30H46O4 |
| 176390-68-4 | 16alpha-Hydroxytrametenolic acid | C30H48O4 |
| 176391-41-6 | ONO-AP 500-02 | C26H24N2O4 |
| 176433-49-1 | 2,5-Dichloropyridine-3-carboxaldehyde | C6H3Cl2NO |
| 176445-77-5 | 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile | C8H14N2O |
| 176445-79-7 | 3-(Aminomethyl)-N,N-dimethyltetrahydrothiophen-3-amine | C7H16N2S |
| 176447-94-2 | N-Desmethyldofetilide | C18H25N3O5S2 |
| 176486-63-8 | N-Boc-trans-4-N-Fmoc-amino-L-proline | C25H28N2O6 |
| 176492-83-4 | N-(4-Ethylenedioxycylohexyl)-1-amino-2,2-diethoxyethane | C14H27NO4 |
| 176504-36-2 | 3-[1-[3-(Dimethylamino)propyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride | C25H24N4O2.HCl |
| 176504-70-4 | 2-Bromo-6-methylbenzaldehyde | C8H7BrO |
| 176508-81-9 | 4-Cyano-3-fluorobenzoic acid | C8H4FNO2 |
| 176519-75-8 | 8-Hydroxyodoroside A | C30H46O8 |
| 176520-13-1 | Scutebarbatine A | C32H34N2O7 |
| 176526-00-4 | 2-(4-Pyridyl)benzaldehyde | C12H9NO |
| 176530-47-5 | 4-Chloro-2-(methylthio)thieno[3,2-d]pyrimidine | C7H5ClN2S2 |
| 176548-70-2 | 3-Bromo-5-fluorobenzoic acid | C7H4BrFO2 |
| 176548-72-4 | 3-Fluoro-5-methoxybenzoic acid | C8H7FO3 |
| 176548-87-1 | 1-(3-Fluoro-5-methoxyphenyl)ethanone | C9H9FO2 |
| 176590-86-6 | 2-Amino-4-(trifluoromethyl)-5-thiazolecarboxylic acid phenylmethyl ester | C12H9F3N2O2S |
| 176591-49-4 | Human urocortin I | C204H337N63O64 |
| 176593-07-0 | (R)-alpha-Methylbenzenemethanamine compd. with [R-[R*,S*-(E)]]-ethyl 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoate | C27H28FNO4.C8H11N |
| 176598-10-0 | (1S,2S,3S,4R)-2-[(Acetyloxy)methyl]-5-cyclohexene-1,2,3,4-tetrol 1,4-dibenzoate | C23H22O8 |
| 176644-21-6 | Eniporide | C14H16N4O3S |
| 176655-56-4 | Ritonavir EP Impurity E | C37H48N6O6S2 |
| 176665-78-4 | Ducheside A | C20H16O12 |
| 176672-49-4 | 4-(tert-Butoxy)phenylboronic acid | C10H15BO3 |